PharmaCyte Biotech Inc (PMCB) Financials

$0.49

$0.00 (0.51%)

As on 08-Sep-2026 16:16EDT

Market cap

$5 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17	Apr-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Operating Expenses	6.85	4.38	8.52	6.46	4.39	3.62
Operating Profit (EBIT)	-6.85	-4.38	-8.52	-6.46	-4.39	-3.62
Other Income	--	--	--	--	--	--
Profit before Tax	-19.42	30.66	0.33	-4.32	-4.24	-3.55
Provision for Tax	--	--	-6.52	-1.94	-0.15	0.00
Profit after Tax (Net Income)	-19.42	30.66	0.33	-4.32	-4.24	-3.55
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-4.24	-3.55

Liabilities ($ Mln)	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17	Apr-16
Shareholder's Funds	33.29	51.89	39.51	72.69	89.92	6.68
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	9.26	0.36	12.97	--	0.21	0.17
Current Liabilities	0.83	2.91	7.42	0.59	0.70	0.72
Total Liabilities	46.75	55.17	59.90	73.28	90.62	7.40

Assets ($ Mln)	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17	Apr-16
Non-Current Assets	9.33	32.79	9.46	5.13	5.13	5.13
Current Assets	37.42	22.38	50.44	68.15	85.49	2.28
Total Assets	46.75	55.17	59.90	73.28	90.62	7.40
Total Debt*	--	--	--	--	--	0.05
Net Current Assets	36.59	19.46	43.02	67.56	84.79	1.55

Cashflow ($ Mln)	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17	Apr-16
Cash From Operating Activities	-5.15	-2.98	-2.15	-3.79	-4.12	-3.33
Cash Flow from Investing Activities	2.00	-7.00	-5.00	--	--	--
Cash from Financing Activities	6.58	-25.03	-10.71	-13.56	87.31	4.64
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17	Apr-16
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17	Apr-16
ROCE (%)	-45.61	67.08	0.59	-5.31	-8.77	-59.71
ROE (%)	-45.61	67.08	0.59	-5.31	-8.78	-60.35
ROA (%)	-38.12	53.28	0.50	-5.27	-8.65	-52.34
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17	Apr-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	--	7,773.36	103.10	-24.79	-20.36	-87.41
Net Profit Growth (%)	-163.36	9,084.98	107.73	-1.81	-19.37	7.20
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17	Apr-16
Price / Earnings	--	--	--	--	--	--
Price / Book Value	--	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	6.99	3.55	7.70	10.54	20.15	0.61
Close Price ($)	0.72	1.24	2.12	2.92	2.33	26.55
High Price ($)	1.51	2.42	3.23	3.10	31.05	55.50
Low Price ($)	0.63	1.03	1.92	1.95	1.79	6.00
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17	Apr-16
Debt to Equity	--	--	--	--	--	0.01
Short term debt to equity ratio	--	--	--	--	--	0.01
Current Ratio	45.28	7.68	6.80	116.18	121.38	3.14
Quick Ratio	--	--	--	--	--	--
Interest Coverage	--	--	--	--	-16,956.81	-2,354.29

Operating Efficiency Ratios	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17	Apr-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--